Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.6%

1 terminated/withdrawn out of 162 trials

Success Rate

96.2%

+9.7% vs industry average

Late-Stage Pipeline

7%

11 trials in Phase 3/4

Results Transparency

0%

0 of 25 completed trials have results

Key Signals

63 recruiting

Enrollment Performance

Analytics

N/A
47(42.7%)
Early Phase 1
23(20.9%)
Phase 1
15(13.6%)
Phase 2
14(12.7%)
Phase 4
6(5.5%)
Phase 3
5(4.5%)
110Total
N/A(47)
Early Phase 1(23)
Phase 1(15)
Phase 2(14)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (162)

Showing 20 of 162 trials
NCT06284642Phase 4Recruiting

Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)

Role: collaborator

NCT07013461Recruiting

International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer

Role: collaborator

NCT07562438Phase 2Recruiting

Prospective Clinical Trial of 177Lu-P17-088 in the Treatment of Metastatic Castration-Resistant Prostate Cancer

Role: lead

NCT07117760Phase 1Active Not Recruiting

Prospective Clinical Trial of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant Prostate Cancer

Role: lead

NCT07513844Not ApplicableRecruiting

Optimizing Parameters of Low-Intensity Focused Ultrasound for Pallidal Modulation in Huntington's Disease

Role: lead

NCT07547098Recruiting

Study on Construction of Whole Lifecycle Cohort, Big Data Management and Clinical Prognosis of Cardio-Renal-Metabolic (CKM) Syndrome

Role: lead

NCT06421142Not ApplicableActive Not Recruiting

FAPI and FDG PET/MRI in Diagnosis and Therapy Prediction of Bladder Cancer

Role: lead

NCT06737913Phase 2Recruiting

HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma

Role: collaborator

NCT07089862Not ApplicableRecruiting

INdobufen Versus asPirin in Endovascular Unruptured Intracranial Aneurysms Treatment (INPUT)

Role: collaborator

NCT07459296Phase 3Recruiting

Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC

Role: collaborator

NCT06265051Phase 2Completed

Tirofiban After Successful MT Recanalization in AIS

Role: collaborator

NCT07350850Phase 2Recruiting

A Multicenter Two-Cohort Study of Methotrexate, Rituximab, Sintilimab and Pirtobrutinib for Treatment-Naive PCNSL vs. Real-World Investigator-Selected Treatment (Observational Cohort)

Role: collaborator

NCT07438119Phase 4Not Yet Recruiting

Efficacy Comparison of DExamethasone Intravitreal Implant Combined With Aflibercept Versus Aflibercept Monotherapy in Treatment-naïve Inflammatory Diabetic Macular Edema Patients

Role: collaborator

NCT06358209Not ApplicableRecruiting

Safety and Efficacy of Ventricular Irrigation for Ventriculitis

Role: collaborator

NCT06919822Not ApplicableRecruiting

SCAN Targeted Epidural Modulation for Parkinson's Disease

Role: collaborator

NCT07419516Completed

MRA Diameter as a Predictor for LLN Metastasis in Rectal Cancer.

Role: lead

NCT07405346Not ApplicableEnrolling By Invitation

A Trial for Advanced Leiomyosarcoma With Human Organoid-guided Personalized Efficacy

Role: collaborator

NCT07130955Not ApplicableEnrolling By Invitation

A Randomized Trial of Six-Channel RF Ablation System for Renal Denervation in Uncontrolled Hypertension and Chronic Kidney Disease

Role: collaborator

NCT07402525Not ApplicableRecruiting

Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective, Multicenter, Randomized Controlled, Open-labelled Trial

Role: collaborator

NCT07378358Recruiting

Evaluation of AI Large Models for Diagnosis and Treatment in Real-World Cases: Multicenter Retrospective Study

Role: lead